These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder. Tikka SK; Garg S; Das B Indian J Pharmacol; 2013; 45(5):532-3. PubMed ID: 24130396 [TBL] [Abstract][Full Text] [Related]
3. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. Fennig S; Fennig SN; Pato M; Weitzman A Br J Psychiatry; 1994 Jun; 164(6):839-41. PubMed ID: 7952995 [TBL] [Abstract][Full Text] [Related]
4. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology. Sevincok L; Uslu A; Kaynak H; Dereboy F J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992 [No Abstract] [Full Text] [Related]
5. Hyperpigmentation with amisulpride. Mendhekar DN Aust N Z J Psychiatry; 2009 Jan; 43(1):88. PubMed ID: 19086350 [No Abstract] [Full Text] [Related]
7. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493 [TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder. Jefferson JW; Greist JH; Perse TL; Rosenfeld R J Clin Psychopharmacol; 1991 Dec; 11(6):391-2. PubMed ID: 1770160 [No Abstract] [Full Text] [Related]
10. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275 [TBL] [Abstract][Full Text] [Related]
11. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced mania. Mundo E; Ronchi P; Bellodi L Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514 [No Abstract] [Full Text] [Related]
13. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine. Mattes JA Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352 [No Abstract] [Full Text] [Related]
14. Serotonin syndrome from fluvoxamine and buspirone. Baetz M; Malcolm D Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
15. Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description. Diaferia G; Mundo E; Bianchi Y; Ronchi P J Clin Psychopharmacol; 1994 Feb; 14(1):78-9. PubMed ID: 8151009 [No Abstract] [Full Text] [Related]
16. Fluvoxamine for obsessive-compulsive disorder. Med Lett Drugs Ther; 1995 Feb; 37(942):13-4. PubMed ID: 7845314 [No Abstract] [Full Text] [Related]